Once they find such tumor neo-antigens, as they're called, they could design
other immunotherapy strategies that could target them.
Not exact matches
Therefore, «this finding may represent a future therapeutic strategic to combine with
other strategies, such as
immunotherapy, chemotherapy or inhibitors against specific signalling routes of the tumour cells.»
The results show that generation of an optimal immune response to cancer requires cooperation between two types of memory T cell — one circulating in the blood and the
other resident in tissues — that can be reactivated with current
immunotherapy strategies.
Today, two AS aggregate - clearing
immunotherapies have advanced into human testing, with one using an active vaccine approach and the
other a passive mAb infusion
strategy.
We are developing cutting - edge discovery platforms and product
strategies for effective cancer
immunotherapies that we believe take into consideration the limitations of
other approaches, as well as leveraging different mechanisms of action to address the risk of reliance on a single approach.